Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study
Jerome W. Yates(Unknown), JF Holland(Regional Cancer Center), MR Cooper(Regional Cancer Center), Geoffrey Falkson(Regional Cancer Center), M Green(Regional Cancer Center), Harvey Dosik(Regional Cancer Center), O Glidewell(Regional Cancer Center), Nissen Ni(Regional Cancer Center), JL Hutchison(Regional Cancer Center), RR Ellison(Regional Cancer Center), Clark H. Hoagland(Regional Cancer Center), Peter H. Wiernik(Albert Einstein College of Medicine), G. Watson James(Regional Cancer Center), Louis A. Leone(Regional Cancer Center), Peter C. Raich(Regional Cancer Center), D. Steinberg(Regional Cancer Center), Arlan J. Gottlieb(Regional Cancer Center), Farid I. Haurani(Regional Cancer Center), E Henderson(Regional Cancer Center), C.J. Cornell(Regional Cancer Center), RT Silver(Regional Cancer Center), RN Levy(Regional Cancer Center), Jeffrey L. Berenberg(National Cancer Institute), Patrick H. Henry(Regional Cancer Center), Robert W. Frelick(Regional Cancer Center)
Cited by 527
Related Papers
All-<i>trans</i>-Retinoic Acid in Acute Promyelocytic Leukemia
|New England Journal of Medicine|1997|1.1k